KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Adaptive Biotechnologies (ADPT) over the last 5 years, with Dec 2024 value amounting to $147.1 million.

  • Adaptive Biotechnologies' Shares Outstanding (Diluted Average) rose 10.61% to $163.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.2 million, marking a year-over-year increase of 10.61%. This contributed to the annual value of $147.1 million for FY2024, which is 1.88% up from last year.
  • Adaptive Biotechnologies' Shares Outstanding (Diluted Average) amounted to $147.1 million in FY2024, which was up 1.88% from $144.4 million recorded in FY2023.
  • Over the past 5 years, Adaptive Biotechnologies' Shares Outstanding (Diluted Average) peaked at $147.1 million during FY2024, and registered a low of $131.2 million during FY2020.
  • In the last 3 years, Adaptive Biotechnologies' Shares Outstanding (Diluted Average) had a median value of $144.4 million in 2023 and averaged $144.7 million.
  • Data for Adaptive Biotechnologies' Shares Outstanding (Diluted Average) shows a peak YoY grew of 6.96% (in 2021) over the last 5 years.
  • Adaptive Biotechnologies' Shares Outstanding (Diluted Average) (Yearly) stood at $131.2 million in 2020, then grew by 6.96% to $140.4 million in 2021, then climbed by 1.54% to $142.5 million in 2022, then climbed by 1.31% to $144.4 million in 2023, then increased by 1.88% to $147.1 million in 2024.